Cargando…

Primary cervical cancer screening with HPV testing compared with liquid-based cytology: results of round 1 of a randomised controlled trial – the HPV FOCAL Study

BACKGROUND: Round 1 data of human papillomavirus (HPV) FOCAL, a three-arm, randomised trial, which aims to establish the efficacy of HPV DNA testing as a primary screen for cervical cancer, are presented. METHODS: The three arms are: Control arm – liquid based cytology with atypical squamous cells o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ogilvie, G S, Krajden, M, van Niekerk, D J, Martin, R E, Ehlen, T G, Ceballos, K, Smith, L W, Kan, L, Cook, D A, Peacock, S, Stuart, G C E, Franco, E L, Coldman, A J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2012
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3516684/ https://www.ncbi.nlm.nih.gov/pubmed/23169286 http://dx.doi.org/10.1038/bjc.2012.489

Ejemplares similares

A randomized controlled trial of Human Papillomavirus (HPV) testing for cervical cancer screening: trial design and preliminary results (HPV FOCAL Trial)
por: Ogilvie, Gina S, et al.
Publicado: (2010)

Comparison of the Roche cobas® 4800 and Digene Hybrid Capture® 2 HPV tests for primary cervical cancer screening in the HPV FOCAL trial
por: Cook, Darrel A., et al.
Publicado: (2015)

Human papillomavirus‐based screening at extended intervals missed fewer cervical precancers than cytology in the HPV For Cervical Cancer (HPV FOCAL) trial
por: Gottschlich, Anna, et al.
Publicado: (2022)

Disease detection and resource use in the safety and control arms of the HPV FOCAL cervical cancer screening trial
por: Coldman, Andrew J, et al.
Publicado: (2016)

Cost‐effectiveness analysis of primary human papillomavirus testing in cervical cancer screening: Results from the HPV FOCAL Trial
por: Cromwell, Ian, et al.
Publicado: (2021)

Women’s acceptability of and experience with primary human papillomavirus testing for cervix screening: HPV FOCAL trial cross-sectional online survey results
por: Smith, Laurie W, et al.
Publicado: (2021)

Willingness to Self-Collect a Sample for HPV-Based Cervical Cancer Screening in a Well-Screened Cohort: HPV FOCAL Survey Results
por: Lesack, Anne, et al.
Publicado: (2022)

Evaluation of a validated methylation triage signature for human papillomavirus positive women in the HPV FOCAL cervical cancer screening trial
por: Cook, Darrel A., et al.
Publicado: (2018)

Cytological Evaluation and REBA HPV-ID HPV Testing of Newly Developed Liquid-Based Cytology, EASYPREP: Comparison with SurePath
por: Lee, Youn Soo, et al.
Publicado: (2013)

Quality control for normal liquid-based cytology: Rescreening, high-risk HPV targeted reviewing and/or high-risk HPV detection?
por: Depuydt, Christophe E, et al.
Publicado: (2009)

Anal High-risk HPV and Liquid-based Cytology of Immunocompetent Brazilian Women with Genital High-risk HPV
por: Melo, Karla Maria Rêgo Leopoldo, et al.
Publicado: (2022)

Triage of HPV-positive women in Norway using cytology, HPV16/18 genotyping and HPV persistence
por: Arbyn, Marc, et al.
Publicado: (2020)

Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to women with normal cytology in The Netherlands
por: Bulk, S, et al.
Publicado: (2006)

The impact of knowledge of HPV positivity on cytology triage in primary high-risk HPV screening
por: Aitken, Clare A, et al.
Publicado: (2019)

Transience of cervical HPV infection in sexually active, young women with normal cervicovaginal cytology.
por: Hinchliffe, S. A., et al.
Publicado: (1995)

Prevalence of “unclassified” HPV genotypes among women with abnormal cytology
por: Annunziata, Clorinda, et al.
Publicado: (2018)

Prevalence and determinants of HPV infection among Colombian women with normal cytology
por: Molano, M, et al.
Publicado: (2002)

Comparison of HPV-16 and HPV-18 Genotyping and Cytological Testing as Triage Testing Within Human Papillomavirus–Based Screening in Mexico
por: Torres-Ibarra, Leticia, et al.
Publicado: (2019)

Whole tissue cervical mapping of HPV infection: Molecular evidence for focal latent HPV infection in humans
por: Hammer, Anne, et al.
Publicado: (2019)

CDC Grand Rounds: Reducing the Burden of HPV-Associated Cancer and Disease
por: Dunne, Eileen F., et al.
Publicado: (2014)

Primary screening for cervical cancer precursors by the combined use of liquid-based cytology, computer-assisted cytology and HPV DNA testing
por: Vassilakos, P, et al.
Publicado: (2002)

HPV-specific risk assessment of cervical cytological abnormalities
por: Zhong, Guanglei, et al.
Publicado: (2021)

Evolution and Taxonomic Classification of Alphapapillomavirus 7 Complete Genomes: HPV18, HPV39, HPV45, HPV59, HPV68 and HPV70
por: Chen, Zigui, et al.
Publicado: (2013)

Women’s intentions to self-collect samples for human papillomavirus testing in an organized cervical cancer screening program
por: Smith, Laurie W, et al.
Publicado: (2014)

Evolution and Taxonomic Classification of Human Papillomavirus 16 (HPV16)-Related Variant Genomes: HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67
por: Chen, Zigui, et al.
Publicado: (2011)

Primary Screening for Cervical Cancer Based on High-Risk Human Papillomavirus (HPV) Detection and HPV 16 and HPV 18 Genotyping, in Comparison to Cytology
por: Agorastos, Theodoros, et al.
Publicado: (2015)

A Population-Based Evaluation of a Publicly Funded, School-Based HPV Vaccine Program in British Columbia, Canada: Parental Factors Associated with HPV Vaccine Receipt
por: Ogilvie, Gina, et al.
Publicado: (2010)

High-Risk HPV Genotype Distribution According to Cervical Cytology and Age
por: Trama, Jason P, et al.
Publicado: (2022)

HPV-positive women with normal cytology remain at increased risk of CIN3 after a negative repeat HPV test
por: Polman, Nicole J, et al.
Publicado: (2017)

Monitoring the impact of HPV vaccine in males—Considerations and challenges
por: Brotherton, Julia M.L., et al.
Publicado: (2016)

Molecular tests for human papillomavirus (HPV), Chlamydia trachomatis and Neisseria gonorrhoeae in liquid-based cytology specimen
por: Lee, Sin Hang, et al.
Publicado: (2009)

Comparison of HPV genotyping and methylated ZNF582 as triage for women with equivocal liquid-based cytology results
por: Liou, Yu-Ligh, et al.
Publicado: (2015)

Accuracy of liquid-based brush cytology and HPV detection for the diagnosis and management of patients with oropharyngeal and oral cancer
por: Castillo, Paola, et al.
Publicado: (2021)

Significance of HPV-58 Infection in Women Who Are HPV-Positive, Cytology-Negative and Living in a Country with a High Prevalence of HPV-58 Infection
por: Song, Joon Seon, et al.
Publicado: (2013)

Effects of an Additional Liquid Based Cytology Prepate on Cytological Diagnosis in High-Risk HPV Positive, PaP Test Negative Cases
por: Şahin, Davut, et al.
Publicado: (2019)

Long-term CIN3+ risk in women with abnormal cytology; role of hrHPV testing
por: Kocken, M, et al.
Publicado: (2012)

CIN2+ detection of the HPV DNA Array genotyping assay in comparison with the Cobas 4800 HPV test and cytology
por: Pesic, Aleksandra, et al.
Publicado: (2019)

Risk factors for cytological progression in HPV 16 infected women with ASC-US or LSIL: The Korean HPV cohort
por: So, Kyeong A, et al.
Publicado: (2018)

14-type HPV mRNA test in triage of HPV DNA-positive postmenopausal women with normal cytology
por: Asciutto, Katrin Christine, et al.
Publicado: (2020)

Evaluation of partial genotyping with HPV16/18 for triage of HPV positive, cytology negative women in the COMPACT study
por: Hanley, Sharon J.B., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6e37polin44eukhqllf4liqp1g